drugset / Trial / NCT00384436

Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients

NCT00384436

Phase 4 Completed 580 enrolled Forest Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of escitalopram to an active comparator in severely depressed patients

Timeline

Start
2006-10
Primary completion
2007-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg